DEFINIGEN RESEARCH LIMITED
Company number 11666409 · Monitor this company
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-11-08
- Registered office
- MONETA B280 BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, ENGLAND, CB22 3AT
- Postcode
- CB22 3AT
- Capital
- 1 GBP
- Accounts category
- NO ACCOUNTS FILED
Accounts
- Financial year end
- 30 November
Confirmation statement
- Last statement dated
- 2019-11-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current
MR NICHOLAS TAIT
Secretary
DR MARCUS YEO
Director
Group structure
Controlled by PIXL BIO LTD — since 2018-11-08
From persons-with-significant-control filings on the public register.
Contact details
- Website
- definigen.com
- Phone
- +44 1223497113
Human iPSC-derived hepatocytes, organoids and AI-powered Cell Painting for predictive drug discovery. Trusted by AstraZeneca, Sanofi, Deep Genomics, and many more.
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.